Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefModule

From GxPlex

Jump to: navigation, search

Text

Module number this reference belongs to.

previous 202050100250500next 20
Showing 20 pages using this property.
N
N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 - +
6  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 4 +
6  +
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 77 Paragraph 4 – 5 +
6  +
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 77 Paragraph 6 – 7 +
6  +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 73 Paragraph 5 +
6  +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 77 Paragraph 4 – 5 +
6  +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 77 Paragraph 6 – 7 +
6  +
EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 2. ; 3. +
6  +
EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.4.3 +
6  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42b +
6  +
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-003 +
6  +
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 64 Absatz 3 +
6  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63f (4) +
6  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63g (4) +
6  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 67 (6) - NIS +
6  +
DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Start +
6  +
G
GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.3.7 +
6  +
GBR HRA - Ending your project 28-Jan-2025 - +
6  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.64 (c) - (d) +
6  +
USA 21 CFR Part 312 09-Apr-2025 § 312.33 (a) (3) +
6  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefModule&oldid=20453"